Wealth Alliance Advisory Group, LLC Gilead Sciences, Inc. Transaction History

Wealth Alliance Advisory Group, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$77.31 - $88.08 $10,436 - $11,890	-135 Reduced 5.28%	2,423 $201,000
Q4 2022 Jan 17, 2023	SELL	$62.32 - $89.47 $53,906 - $77,391	-865 Reduced 25.27%	2,558 $0
Q3 2022 Oct 12, 2022	BUY	$59.54 - $68.01 $203,805 - $232,798	3,423 New	3,423 $211,000
Q2 2022 Jul 08, 2022	SELL	$57.72 - $65.01 $234,227 - $263,810	-4,058 Closed	0 $0
Q1 2022 Apr 18, 2022	SELL	$57.92 - $72.58 $3,533 - $4,427	-61 Reduced 1.48%	4,058 $241,000
Q1 2021 Apr 28, 2021	BUY	$60.0 - $68.46 $247,140 - $281,986	4,119 New	4,119 $266,000
Q2 2020 Jul 08, 2020	SELL	$72.34 - $84.0 $200,237 - $232,512	-2,768 Closed	0 $0
Q1 2020 Apr 15, 2020	BUY	$62.63 - $80.22 $173,359 - $222,048	2,768 New	2,768 $207,000
Q4 2018 Jan 28, 2019	SELL	$60.54 - $79.0 $245,187 - $319,950	-4,050 Closed	0 $0
Q3 2018 Oct 19, 2018	BUY	$71.28 - $78.92 $7,128 - $7,892	100 Added 2.53%	4,050 $313,000
Q2 2018 Jul 20, 2018	SELL	$64.88 - $75.68 $42,172 - $49,192	-650 Reduced 14.13%	3,950 $280,000
Q1 2018 Jun 01, 2018	BUY	$72.84 - $88.8 $335,064 - $408,480	4,600 New	4,600 $347,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Wealth Alliance Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Alliance Advisory Group, LLC with notifications on news.